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In this study, we have documented an essential role for ADP-ribosylation factor 6 (ARF6) in cell surface
remodeling in response to physiological stimulus and in the down regulation of stress fiber formation. We
demonstrate that the G-protein-coupled receptor agonist bombesin triggers the redistribution of ARF6- and
Rac1-containing endosomal vesicles to the cell surface. This membrane redistribution was accompanied by
cortical actin rearrangements and was inhibited by dominant negative ARF6, implying that bombesin is a
physiological trigger of ARF6 activation. Furthermore, these studies provide a new model for bombesin-
induced Rac1 activation that involves ARF6-regulated endosomal recycling. The bombesin-elicited transloca-
tion of vesicular ARF6 was mimicked by activated Gaq and was partially inhibited by expression of RGS2,
which down regulates Gq function. This suggests that Gq functions as an upstream regulator of ARF6
activation. The ARF6-induced peripheral cytoskeletal rearrangements were accompanied by a depletion of
stress fibers. Moreover, cells expressing activated ARF6 resisted the formation of stress fibers induced by
lysophosphatidic acid. We show that the ARF6-dependent inhibition of stress fiber formation was due to an
inhibition of RhoA activation and was overcome by expression of a constitutively active RhoA mutant. The
latter observations demonstrate that activation of ARF6 down regulates Rho signaling. Our findings under-
score the potential roles of ARF6, Rac1, and RhoA in the coordinated regulation of cytoskeletal remodeling.
The ADP-ribosylation factor (ARF) proteins comprise a
group of five Ras-related GTPases that are thought to function
as regulators of membrane traffic. In vitro, the ARF proteins
function as cofactors in the cholera toxin-catalyzed ADP-ribo-
sylation of Gs (21, 36), hence its name, and have also been
shown to stimulate the activity of phospholipase D (4, 6, 16, 25,
31). ARF1 has been extensively investigated; it is localized to
the Golgi apparatus and plays a critical role in the recruitment
of coat proteins during the formation of transport vesicles, a
process critical for maintaining the integrity of the secretory
pathway (37). Recently, much attention has been focused on
ARF6, the least-conserved ARF protein that shares 66%
amino acid homology with ARF1. ARF6 is localized to the
plasma membrane and endosomes depending on its nucleotide
status and has been shown to regulate endocytic traffic at the
cell periphery (8, 42, 45).
Immunoelectron microscopy observations in CHO cells have
revealed that expression of the GTP-bound constitutively ac-
tivated mutant of ARF6, ARF6(Q67L), induced an elabora-
tion of the plasma membrane and a depletion of recycling
endosomal vesicles. In contrast, the expression of the dominant
negative mutant of ARF6, ARF6(T27N), resulted in seques-
tration of ARF6 in the perinuclear recycling endosome, the
distribution of which partially overlapped with that of trans-
ferrin receptors and cellubrevin (10). These findings, together
with the observation that ARF6(T27N) expression inhibited
the recycling of ligands to the plasma membrane, led to the
speculation that nucleotide exchange of ARF6 triggered the
redistribution of endosomal membrane to the cell surface (8,
10, 45). The ARF6-induced redistribution of endosomal mem-
brane was accompanied by a rearrangement of the cortical
actin cytoskeleton (9, 44). In CHO cells, expression of ARF6
induced the formation of actin-rich microvillus-like protru-
sions at the cell surface and a depletion of stress fibers (9).
These actin rearrangements were distinct from those induced
by the expression of activated mutant forms of the Rho family
GTPases Cdc42, Rac1, and RhoA.
The Rho family GTPases regulate the assembly and organi-
zation of the actin cytoskeleton and have more recently also
been implicated in the regulation of transcriptional activation,
cell cycle progression, and cell transformation (15, 53). In
fibroblasts, activation of Cdc42 and Rac results in the forma-
tion of filopodia and lamellipodia, respectively (23, 39, 48),
whereas Rho activation induces the formation of stress fibers
(49). These GTPases may also function in a hierarchical sig-
naling cascade in which the activation of Cdc42 leads to the
activation of Rac, which in turn activates Rho (38).
We had previously shown that ARF6-mediated peripheral
actin rearrangements were regulated by POR1, a Rac1-inter-
acting protein that plays a role in Rac1-induced membrane
ruffling (9, 53). As previously observed for Rac1, ARF6 in its
GTP-bound conformation interacted with POR1 and deletion
mutants of POR1 blocked ARF6-mediated cytoskeletal rear-
rangements. The dominant negative mutants of either GTPase,
ARF6 or Rac1, did not interfere with actin rearrangements
mediated by the other, which lead us to conclude that ARF6
and Rac1 functioned in parallel rather than on a linear signal-
ing pathway. In addition to interacting with POR1, Rac1 and
ARF6 have been implicated in regulated secretion in mast cells
and adrenal chromaffin cells, respectively (13, 41), and they
both inhibit receptor-mediated endocytosis (8, 26). More re-
cently, it was demonstrated that Rac1 colocalized with ARF6
in a perinuclear recycling compartment in HeLa cells and that
pharmacological agents such as aluminum fluoride (AlF)
shifted the distribution of vesicle-associated ARF6 and Rac1
to the plasma membrane (46). These findings suggest that actin
rearrangements induced by ARF6 and Rac1 are coupled to
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movement of intracellular membrane-associated ARF6 and
Rac1 to the plasma membrane. Several observations support
the contention that exit sites of recycling endosomal mem-
brane at the cell surface are polarized and that this membrane
recycling is coupled to the formation of actin-based structures
at the leading edge (2, 20, 28). Furthermore, studies have
shown that endosomal membrane recycling appears to be pro-
moted or enhanced by a physiological stimulus. Treatment of
KB cells with epidermal growth factor resulted in the forma-
tion of membrane ruffles that are enriched in endosomal li-
gands such as transferrin receptors (3). Various growth factors
and bioactive lipids induce cytoskeletal rearrangements by ac-
tivation of the Rho family GTPases. For example, membrane
ruffling induced by platelet-derived growth factor (PDGF),
insulin, and bombesin is mediated by the Rac1 GTPase (18, 39,
49), whereas lysophosphatidic acid and bombesin induce stress
fiber formation via the activation of Rho (48). Given our pre-
vious observations that activated ARF6 induces rearrange-
ments of the cortical actin cytoskeleton, we were interested in
determining whether ARF6 mediates actin remodeling trig-
gered by one or more extracellular agonists.
In this study, we report that the G-protein-coupled agonist
bombesin triggers the redistribution of endosomal ARF6 and
Rac1 to the plasma membrane, resulting in peripheral actin
rearrangements. The bombesin-induced recruitment of vesi-
cle-associated ARF6 and Rac1 to the plasma membrane was
dependent on ARF6 activation. Furthermore, we show that
activated Gq mimicked the effect of bombesin by promoting
the translocation of ARF6 to the cell surface, suggesting that
Gq functions as an upstream regulator of ARF6 activation.
The ARF6-induced peripheral rearrangements were accompa-
nied by a diminution of stress fibers. Moreover, cells expressing
activated ARF6 did not exhibit stress fiber formation upon
treatment with LPA (lysophosphatidic acid). We show that this
ARF6-dependent decrease in stress fiber formation in re-
sponse to LPA was due to an inhibition of RhoA activation.
Thus, while ARF6 functions in concert with Rac1 to enhance
membrane ruffling, the ARF6 and Rho pathways appear to be
antagonistic.
MATERIALS AND METHODS
Cells, plasmids, antibodies, and reagents. TRVb-1 cells, a CHO (Chinese
hamster ovary) cell line that overexpresses transferrin receptors (31), were grown
and maintained in Ham’s F-12 medium (Gibco-BRL, Grand Island, N.Y.) sup-
plemented with 5% fetal bovine serum (FBS), penicillin-streptomycin, and 100
mg of G418 per ml. Mammalian expression plasmids encoding wild-type and
mutant derivatives of ARF6, Rac1, and RhoA that were used in this study have
been previously described (8, 9, 11). To generate hemagglutinin (HA)-tagged
ARF6, wild-type ARF6 cDNA was amplified by PCR by using a 59 primer
containing an XbaI restriction site and N-terminal sequence of ARF6 and a 39
primer containing an XbaI restriction site, the HA epitope, and the C-terminal
sequence of ARF6. The PCR product was subcloned into the XbaI site of
pcDNA3-1 (Clontech). Sequence and orientation was confirmed by DNA se-
quencing. Mammalian expression plasmids encoding Gaq(R183C) and RGS2 were
generously provided by Ken Blumer (Washington University) and Gai3(Q204L)
was kindly provided by Maurine Linder (Washington University). Bacterial ex-
pression plasmid RBD (Rho binding domain)-pGEX, was kindly provided by
Martin Schwartz (Scripps Research Institute). C1199Tiam1:pCDNA and anti-
Tiam 1 polyclonal antibodies were generous gifts from John Collard and Frank
van Leeuwen (Netherlands Cancer Institute). For Rac1 localization studies,
affinity-purified anti-Rac1 mouse monoclonal antibody (Transduction Laborato-
ries, Lexington, Ky.) and anti-Rac1 peptide rabbit polyclonal antibodies (Santa
Cruz Biotechnology, Inc., Santa Cruz, Calif.) were used. ARF6 was localized by
using an affinity-purified anti-ARF6 antisera previously described (8). Affinity-
purified anti-Gq polyclonal antibody was from Santa Cruz Biotechnology, Inc.
Fluorescein and Rhodamine-conjugated donkey anti-rabbit and donkey anti-
mouse anti-immunoglobulin G was purchased from ICN, Costa Mesa, Calif.
Anti-HA and anti-FLAG epitope monoclonal antibodies were from Boehringer
Mannheim Biochemicals, Indianapolis, Ind., and Kodak IBI, respectively. Rho-
damine phalloidin was from Molecular Probes, Eugene, Oreg. Exoenzyme C3
transferase and PDGF-b were from Calbiochem-Behring, La Jolla, Calif. LPA,
bombesin, and all other chemicals were obtained from Sigma Chemical Co., St.
Louis, Mo.
Expression of ARF6 and Rac1 proteins by using the Sindbis virus expression
system. ARF6 and Rac1 proteins were expressed in TRVb-1 cells when the
Sindbis virus was used as an expression vector. Recombinant virus encoding
ARF6 and its mutant derivatives were generated as previously described (8). A
virus titer of 50 PFU/cell was used for cell infection. Adsorption was conducted
at room temperature for 1 h in 250 ml of phosphate-buffered saline (PBS)
containing 1% FBS. The infection mixtures were replaced by 2 ml of Ham’s F-12
medium containing 3% FBS, and cells were maintained at 37°C. Experiments
were performed 4 h postinfection. For examination of protein expression, cells
were lysed in 1% sodium dodecyl sulfate (SDS). Cell lysates were analyzed by
SDS-polyacrylamide gel electrophoresis (PAGE), were transferred to nitrocel-
lulose membranes, and were blotted for ARF6 and/or Rac by using monoclonal
antibodies directed against ARF6 and Rac1 (Transductions Laboratories), re-
spectively. ARF6 and Rac wild-type and mutant proteins migrated as 20-kDa
bands (data not shown), and the level of protein expression was approximately
fivefold higher than endogenous levels.
Fluorescence microscopy procedures. CHO cells on coverslips were fixed with
2% paraformaldehyde for 30 min, were permeabilized, and were quenched with
PBS containing 0.05% Triton X-100, 0.1 N NH4Cl, and 0.2% gelatin. After
permeabilization, cells were first incubated with appropriate primary antibodies
for 2 h at room temperature. Cells were washed and then incubated with flu-
orophore-conjugated secondary antibodies with or without rhodamine phalloi-
din. Cells were mounted in 70% glycerol (in PBS) and were visualized by using
a Zeiss axiovert microscope and a Bio-Rad confocal scanning imaging system.
Electroporation procedures. Expression plasmids ARF6(Q67L)-pCDNA3-1
and Rho(G14V)-pCGT, or HA-tagged ARF6-pCDNA3-1 and Gaq(R183C)-
PCMV5 or Gai3(Q204L)-PC15, or ARF6-pCDNA3-1 and RGS2-PEGFP-C1
were transected into TRVb-1 cells by electroporation by using a Bio-Rad cell
electroporator according to the manufacturer’s instructions. Briefly, 3 3 106
exponentially growing cells were trypsinized and suspended in a total volume of
400 ml of PBS containing 15 mg of each plasmid DNA. Cells were electroporated
at 260 V and 960 mF. Electroporated cells were suspended in 2 ml of growth
medium, were seeded on glass coverslips, and were analyzed for protein expres-
sion and actin filament rearrangements 24 to 36 h after transfection.
Cell microinjection. Cells on coverslips were microinjected by using a Narash-
igie microinjection system according to the manufacturer’s instructions with 0.3
mg of ARF6(Q67L) per ml alone or along with 100 mg of exoenzyme C3
transferase per ml. Following injection, cells were incubated in growth media at
37°C. At 2 to 2.5 h postinjection, cells were fixed and processed for indirect
immunofluorescence microscopy. Recombinant ARF6(Q67L) used for these
studies was expressed in BL21-DE3 bacteria cotransfected with bacterial expres-
sion plasmids encoding ARF6(Q67L) and n-myristoyltransferase (kindly pro-
vided by Richard Klausner, National Institutes of Health) as previously described
(8). myrARF6(Q67L) was purified as previously described (30).
GTP loading of ARF6 in intact cells. CHO cells (106) were transfected with 15
mg of HA-tagged ARF6 plasmid DNA by using electroporation and were seeded
into three wells of a six-well tissue culture plate. Cells were maintained at 37°C
for 24 h in growth media, after which the media were replaced by serum-free and
phosphate-free media containing 250 mCi of [32P]orthophosphate per ml for
16 h. Preparation of cell lysates and immunoprecipitation of bound ARF6 was
performed as described by Langille et al. (27), except that anti-HA monoclonal
antibody was used for immunoprecipitation. Elution and separation of bound
nucleotides by thin-layer chromatography was carried out as described (27).
Chromatography plates were subjected to autoradiography.
MAPK and JNK assays. For monitoring activation by mitogen-activated pro-
tein kinase (MAPK), CHO cells were cotransfected (by lipofectamine method)
with 5 mg of HA-tagged p42MAPK and 5 mg of vector pcDNA3-1, HRasV12-
pcDNA3-1, ARF6(Q67L)-pcDNA3-1, or ARF6(T27N)-pcDNA3-1. After an 8-h
incubation with the complexes, cells were incubated in 5% FBS-containing media
for 16 h and then were incubated for 12 h in serum-free media. Cells were treated
with or without bombesin (0.2 mM) for 10 min at 30°C. Cells were then lysed and
immunoprecipitated with anti-HA monoclonal antibody 12CA5. Immune com-
plexes were collected by binding to protein A-Sepharose, were washed exten-
sively with lysis buffer, and then were incubated for 30 min at 30°C in kinase assay
buffer (20 mM Tris [pH 7.4], 20 mM MgCl2, 2 mM MnCl2, 1 mM Na3VO4, 20
mM ATP) and 10 mCi of [g-32P]ATP, with 0.2 mg of myelin basic protein per ml
as a substrate. The reaction products were analyzed by SDS-PAGE and were
visualized by autoradiography. The presence of immunoprecipitated HA-MAPK
was assessed by using anti-HA monoclonal antibody 12CA5. Expression of ARF6
and Ras proteins was verified by using polyclonal antibody against ARF6 and
anti-HA monoclonal antibody 12CA5 for Ras. For measurements of c-Jun N-
terminal kinase (JNK) activity, CHO cells were cotransfected with 5 mg of
HA-tagged JNK and 5 mg of vector pcDNA3-1, ARF6(T27N)-pcDNA3-1,
RacV12-pcDNA3-1, ARF6(Q67L)pcDNA3-1, RacV12-pcDNA3-1 plus vector,
or RacV12-pcDNA3-1 plus ARF6(T27N)-pcDNA3-1. After an 8-h incubation
with the complexes, cells were incubated in 5% FBS-containing media for 16 h
and were then incubated for 12 h in serum-free media. Cells were treated with
or without epidermal growth factor (EGF) (50 ng/ml) for 20 min at 30°C.
Following cell lysis, JNK1 was immunoprecipitated with anti-HA monoclonal
antibody 12CA5, and immune complexes were collected by binding to protein
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A-Sepharose and were incubated with glutathione S-transferase (GST)–N-ter-
minal c-Jun (3 mg/reaction) in kinase assay buffer for 30 min at 30°C. The
reaction products were analyzed by SDS-PAGE and were visualized by autora-
diography. Immunoprecipitated HA-tagged JNK was determined by using an-
ti-HA monoclonal antibody 12CA5. The expression of Rac1 and ARF6 proteins
was confirmed by using polyclonal antibodies against Rac1 and ARF6, respec-
tively.
RBD-GST in vitro binding assay. CHO cell lysates were washed with ice-cold
media without serum and were lysed in buffer A (50 mM Tris-HCl [pH 7.2], 0.8%
Triton, 0.1% SDS, 500 mM NaCl, 10 mM MgCl2, and 10 mg of protease cocktail
per ml [Sigma]). Cell lysates were centrifuged at 14,000 3 g at 4°C for 10 min.
Equal volumes of supernatant were incubated with GST–Rho-binding domain
(RBD) immobilized on glutathione-Sepharose on ice for 90 min. The resin was
washed extensively with buffer B (Tris-HCl [pH 7.0], 0.8% Triton, 150 mM NaCl,
10 mM MgCl2, 10 mg of protease cocktail per ml). The washed resin was boiled
in SDS-PAGE sample buffer, and bound proteins were resolved on SDS gels
followed by Western blot analysis by using anti-RhoA polyclonal antibodies
(Santa Cruz Biotechnology).
RESULTS
Endosomal ARF6 translocates to the plasma membrane in
response to physiological stimulus. The Rho GTPases couple
plasma membrane receptors with actin rearrangements in-
duced by specific growth factors and other extracellular ago-
nists (23, 39, 48). For instance, Rac1 is required for PDGF-
stimulated actin polymerization at the cell surface that leads to
the formation of membrane ruffles, whereas LPA-induced
stress fiber formation is mediated by activation of Rho. To
identify extracellular stimuli that induced ARF6 activation,
cells expressing wild-type ARF6 were treated with various
physiological agonists, were fixed, and were labeled with anti-
ARF6 antibody and with rhodamine phalloidin to view actin
filament distribution. Consistent with our prior observations,
wild-type ARF6 localized predominantly to a perinuclear re-
cycling endosomal compartment and had no effect on surface
remodeling (10). Treatment of quiescent CHO cells with the
G-protein-receptor-coupled agonist bombesin induced the re-
distribution of ARF6 from perinuclear endosomes to the cell
surface (Fig. 1A and C). The translocation of vesicular ARF6
to the cell surface was accompanied by surface rearrangements
of the actin cytoskeleton that resembled those induced by the
expression of ARF6(Q67L), the plasma-membrane-associated
and GTP-bound mutant of ARF6 (Fig. 1D). The bombesin-
elicited translocation of endosomal vesicles and cytoskeletal
rearrangements was blocked by expression of ARF6(T27N),
the endosome-associated dominant negative mutant of ARF6
(data not shown). These results indicate that bombesin is a
physiological trigger that elicits the redistribution leading to
peripheral actin rearrangements. The redistribution of ARF6
to the cell periphery was also seen when cells were treated with
EGF, although this response was not as dramatic as that seen
with bombesin treatment (data not shown). In contrast, treat-
ment of cells with PDGF, insulin, and LPA induced actin
rearrangements (membrane ruffles and stress fibers, respec-
tively) but had only a slight effect on the redistribution of
vesicle-associated ARF6 to the plasma membrane (data not
shown). We are presently testing other extracellular agonists
for their ability to redistribute vesicle-associated ARF6 to the
plasma membrane.
Next, we assessed whether stimulation of cells with bomb-
FIG. 1. Bombesin promotes ARF6 activation. (A to D) Bombesin redistrib-
utes ARF6 from perinuclear vesicles to the plasma membrane. Cells transfected
with wild-type ARF6 were treated without (A and B) or with (C and D) 15 nM
bombesin for 15 min at 37°C. Cells were fixed and labeled with affinity-purified
anti-ARF6 polyclonal antibody and were processed for immunofluorescence
microscopy. Cytoskeletal rearrangements were visualized by rhodamine phalloi-
din staining. Untransfected cells in panel D that exhibit stress fibers are indicated
by arrows. (E) GTP loading of ARF6 in intact cells. CHO cells treated with or
without bombesin or EGF as indicated were transfected with HA-tagged ARF6
and were labeled with [32P]orthophosphate. ARF6 was immunoprecipitated with
anti-HA monoclonal antibody, and bound nucleotides were eluted, separated by
thin-layer chromatography, and subjected to autoradiography. The data shown
are representative of three separate experiments.
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esin and EGF increased the levels of ARF6-GTP. For these
studies, cells were transfected with HA-epitope-tagged ARF6
and were labeled with [32P]orthophosphate. The levels of GDP
and GTP bound to ARF6 were assessed as described by Lang-
ille et al. (27). As shown in Fig. 1E, cells treated with bombesin
or EGF exhibited higher levels of ARF6-GTP than untreated
cells.
Bombesin-induced movement of ARF6 to the cell surface is
regulated by Gaq. Since bombesin had the most potent effect
on the translocation of ARF6 to the cell surface, we investi-
gated further the effects of this stimulus on ARF6 distribution.
Heterotrimeric G proteins are likely candidates to play a role
in bombesin-induced activation of ARF6. Studies have indi-
cated that bombesin is a Gq-coupled agonist (55), although
bombesin activation of PLCb in rat acinar cells involved Gai3
(43). To determine whether Gq or Gi3 played a role in ARF6
activation, we coexpressed the activated mutant forms of Gaq,
Gaq(R183C), and Gi, Gai3(Q204L), with wild-type ARF6.
While coexpression of active Gai3 with ARF6 had no effect on
the distribution of either GTPase, the coexpression of acti-
vated Gaq with wild-type ARF6 resulted in the redistribution
of ARF6 and Gq to overlapping sites at the cell surface (Fig.
2). When expressed alone, activated Gq labels the cell surface
and exhibits a punctate distribution with more intense labeling
seen in the perinuclear region (data not shown). To further
assess whether Gq mediates bombesin-induced ARF6 activa-
tion, we examined the effects of RGS2 on ARF6 distribution
and actin rearrangements. RGS (regulators of G-protein sig-
naling) proteins have been shown to exhibit GAP (GTPase-
activating protein) activity by accelerating GTP hydrolysis of
Ga subunits (7, 14). RGS2 has been shown to function as a
GAP for Gaq and to down regulate Gq signaling (19). We
have found that coexpression of RGS2 with ARF6 significantly
decreased the bombesin-induced redistribution of ARF6 to the
plasma membrane (Fig. 2) and hence ARF6-mediated actin
remodeling (data not shown). In contrast, coexpression of
RGS2 with ARF6(Q67L), the ARF6-GTP mutant, had no
effect on ARF6(Q67L)-mediated actin rearrangements (data
not shown). Taken together, these data suggest that Gq may
function as an upstream regulator of ARF6 activation.
Translocation of vesicle-associated ARF6 and Rac1 to the
plasma membrane is regulated by ARF6. Ridley and Hall have
previously shown that in Swiss 3T3 cells, bombesin induced
membrane ruffling via the activation of Rac1 (48). More re-
cently, ARF6 and Rac1 have been shown to colocalize in peri-
nuclear compartments in HeLa cells, and treatment with AlF
induced the redistribution of ARF6 and Rac1 to the cell sur-
face (46). These findings prompted us to examine the distri-
bution of Rac1 in bombesin-treated cells. We began these
investigations by first examining the distribution of Rac1 rela-
tive to ARF6 in CHO cells. Cells were transfected with plas-
mids encoding wild-type ARF6 and wild-type Rac1, were fixed,
were labeled for ARF6 and Rac1, and were examined by in-
direct immunofluorescence microscopy. Notably, wild-type Rac1
exhibited labeling in membrane-bound compartments and dif-
fuse labeling in the cytosol of CHO cells, in contrast to the
exclusive membrane-bound distribution of wild-type Rac1 pre-
viously reported in HeLa cells (46). Membrane-bound Rac1 lo-
calized to the plasma membrane and to intracellular vesicles
at the perinuclear region that partially overlapped with ARF6-
positive perinuclear vesicles (Fig. 3). Wild-type Rac1 alone
exhibited a labeling pattern similar to that observed on coex-
pression with ARF6 (data not shown), indicating that ARF6 ex-
pression did not influence the subcellular distribution of Rac1.
Next, we investigated whether the distribution of Rac1 was
altered in response to bombesin stimulation. Analysis by indi-
rect immunofluorescence of the distribution of Rac1 in bomb-
esin-treated cells transfected with wild-type Rac1 revealed that
the majority of the Rac1 label was present on the plasma
membrane, particularly at the edges of the lamellipodia with
little or no labeling seen in intracellular compartments (Fig. 4).
These results imply that bombesin treatment resulted in the
redistribution of vesicle-associated Rac1 to the leading edge of
the plasma membrane.
Since ARF6 and Rac1 colocalized on intracellular vesicles
and at the cell surface on bombesin treatment, we examined
whether Rac1 translocation to the plasma membrane was in-
fluenced by the ability of ARF6 to promote membrane recy-
cling. Cells cotransfected with wild-type Rac1 and the domi-
nant negative mutant of ARF6, ARF6(T27N), did not exhibit
cytoskeletal rearrangements on treatment with bombesin (data
not shown). Double labeling for ARF6 and Rac1 in these cells
revealed that both GTPases exhibited labeling in a perinuclear
vesicle compartment similar to that observed in untreated cells
(Fig. 4C and D). Thus, coexpression of the dominant interfer-
ing mutant of ARF6 prevented the bombesin-induced redistri-
bution of Rac1 to the cell surface by inhibiting the transloca-
tion of ARF6- and Rac1-positive endosomal vesicles to the
plasma membrane. In a previous study, we showed that ARF6
(T27N) did not inhibit cytoskeletal rearrangements mediated
by Rac1(G12V), the constitutively active and plasma-mem-
brane-associated Rac1 mutant. In support of this observation,
FIG. 2. Effect of Gaq(R183C) and RGS2 on ARF6 distribution. Cells cotransfected with plasmids encoding HA-tagged wild-type ARF6 and Gaq(R183C) were
fixed and labeled with anti-HA monoclonal antibody (left) and affinity-purified anti-Gaq polyclonal antibody (middle) and were processed for immunofluorescence.
Cells cotransfected with plasmids encoding ARF6 and RGS2-GFP were treated with 15 nM bombesin for 15 min and were fixed and labeled with anti-ARF6 antibody
(right). RGS2 expression was monitored by GFP (data not shown). Wild-type ARF6 and Gaq colocalize at the cell surface (arrows), whereas coexpression of RGS2
inhibits the redistribution of ARF6 to the plasma membrane.
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we have also found that coexpression of ARF6(T27N) had no
effect on membrane ruffling mediated by C1199Tiam1, the
constitutively active and plasma-membrane-localized mutant
of the Rac1-GEF, Tiam 1 (data not shown). This supports the
contention that ARF6 promotes bombesin-induced cytoskel-
etal rearrangements by regulating the recruitment of vesicle-
associated Rac1 to the cell surface and does not function in a
linear pathway downstream of Rac1 activation. Taken togeth-
er, the studies described here suggest that ARF6 activation
serves to couple membrane traffic with the organization of the
actin cytoskeleton and provides a role for endosomal mem-
brane recycling in Rac1 activation and membrane ruffling.
ARF6 has no effect on bombesin-induced MAPK activation
or EGF and RacG12V-induced JNK activation. In addition to
rearrangements of the cortical actin cytoskeleton, bombesin
has also been shown to induce the activation of MAPK (5).
Since bombesin treatment led to the redistribution and activa-
tion of ARF6, we investigated whether ARF6 activation played
a role in bombesin-induced activation of MAPK. Towards this
end, CHO cells were cotransfected with either empty vector or
a mammalian expression vector expressing ARF6(T27N) and a
plasmid encoding HA-tagged MAPK. The transfected cells
were serum starved and were treated with bombesin at a con-
centration of 0.2 mM. MAPK activity was assayed in immuno-
precipitates by using myelin basic protein (MBP) as substrate.
As shown in Fig. 5A (right panel), bombesin triggers MAPK
activation; however, expression of ARF6(T27N) had no effect
on bombesin-induced MAPK activation. Furthermore, expres-
sion of the constitutively activated mutant ARF6(Q67L) had
no significant effect on MAPK activation when compared to
that observed on expression of Ras(G12V), a positive con-
trol used in the assay (Fig. 5A, left panel). Taken together,
our findings indicate that bombesin-stimulated MAPK activa-
tion is not mediated by ARF6; however, membrane recruit-
ment and activation of ARF6 is required for bombesin-induced
peripheral cytoskeletal rearrangements.
As described above, we observed that translocation of vesi-
cle-associated ARF6 and Rac1 to the plasma membrane oc-
curs in response to physiological stimuli such as the presence of
bombesin or EGF and that this process is dependent on ARF6-
FIG. 3. Overlapping subcellular distribution of ARF6 and Rac1 in CHO cells. Cells coexpressing wild-type ARF6 and Rac1 were fixed and processed for
immunofluorescence by using affinity-purified antibodies against ARF6 and Rac1. ARF6 localizes predominantly to the perinuclear region of the cell. Rac1 colocalizes
with ARF6 in perinuclear vesicles (arrows) but also exhibits a diffuse cytosolic staining and plasma membrane labeling.
FIG. 4. Bombesin-induced redistribution of Rac1 to the plasma membrane is inhibited by ARF6(T27N). Cells expressing wild-type Rac1 (A and B) or Rac1 plus
ARF6(T27N) (C and D) were treated with 15 nM bombesin for 15 min at 37°C and were fixed and processed for indirect immunofluorescence. Cells expressing Rac1
were labeled with anti-Rac1 monoclonal antibody (A) and with rhodamine phalloidin (B). Cells coexpressing Rac1 and ARF6(T27N) were labeled with anti-Rac1
monoclonal antibody (C) and anti-ARF6 rabbit polyclonal antibody (D). As shown, Rac1 localized to the lamellipodia induced on bombesin treatment. Note the
formation of stress fibers in the cells. Coexpression of ARF6(T27N) prevents the redistribution of Rac1 to the plasma membrane upon bombesin treatment.
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mediated membrane recycling. We were interested in deter-
mining whether this recycling of endosomal ARF6 played a
role in other biological activities mediated by Rac1, in addition
to cytoskeletal rearrangements. It has been previously reported
that the activation of JNK by EGF is in part mediated by Rac1
(34). Hence, we tested the involvement of ARF6 in EGF-
Rac1-stimulated JNK activation. CHO cells were cotransfect-
ed with either empty vector or a mammalian expression vector
expressing ARF6(T27N) and a plasmid encoding HA-tagged
JNK. The transfected cells were serum starved and treated
with EGF at a concentration of 50 ng/ml. JNK activity was as-
sayed by using GST-c-Jun as substrate. Cotransfection with the
ARF6(T27N) construct did not inhibit the activation of HA-
JNK by EGF (Fig. 5B; right panel). Furthermore, coexpression
experiments with ARF6(T27N) and Rac1(G12V) revealed that
ARF6(T27N) had no effect on Rac(G12V)-induced JNK acti-
vation (Fig. 5B, left panel). Expression of ARF6(Q67L) did
not result in a significant increase in JNK activation in CHO
cells although a small, but consistent, increase in JNK activa-
tion was observed when ARF6(Q67L) was expressed in other
cell lines such as 293 cells (data not shown). Nevertheless, in
the latter cell type, ARF6(T2N) had no effect on EGF- or
Rac(G12V)-induced JNK activation (data not shown). The
above findings imply that ARF6 is not involved in EGF-Rac1-
mediated JNK activation and that the requirement of ARF6-
activation for Rac1 function appears to be restricted to cellular
phenomena (such as bombesin-EGF-triggered cytoskeletal re-
arrangements) that necessitate the movement of vesicle-asso-
ciated ARF6 and Rac1 to the plasma membrane. Moreover,
these findings also imply that other ARF6-independent mech-
anisms exist for Rac1 activation.
Activation of ARF6 antagonizes Rho function. As seen in
Fig. 1, the activation of ARF6 by extracellular stimuli induces
peripheral cytoskeletal rearrangements that are accompanied
by a significant decrease in stress fibers. Consistently as previ-
ously described (9), the expression of activated ARF6, ARF6
(Q67L), resulted in a depletion of stress fibers (Fig. 6). We
were interested in determining whether this effect of ARF6
activation on stress fibers was correlated with the activity of
RhoA. Hence, we examined the effect of LPA, the major se-
rum component shown to induce stress fiber formation via the
activation of RhoA (35), on cells expressing activated ARF6.
We have found that quiescent CHO cells expressing ARF6
(Q67L) resisted the formation of stress fibers in response to
treatment with LPA (Fig. 6). In contrast, untransfected cells
exhibited stress fibers within minutes after treatment with
LPA. On more prolonged treatment of ARF6-transfected cells
with LPA, formation of stress fibers was followed by cell
rounding. These findings prompted us to investigate the effects
of ARF6(Q67L) expression on the cellular levels of Rho-GTP
in response to LPA. For these studies, we used an in vitro
binding assay described by Ren et al. (47) which utilizes the
RBD of the Rho effector protein, rhotekin, that interacts ex-
clusively with GTP-bound Rho. The RBD of rhotekin was
FIG. 5. (A) Effects of ARF6 on MAPK kinase activity. CHO cells were cotransfected with 5 mg of HA-tagged MAPK and 5 mg of the indicated constructs. Cells
in lanes 1 and 2 were treated with bombesin (0.2 mM). HA-tagged MAPK was isolated from cell lysates by immunoprecipitation with anti-HA monoclonal antibody
12CA5, and MAPK activity was measured in an immunocomplex kinase assay with MBP as a substrate. Radioactivity incorporated into MBP was visualized by
autoradiography. Expression of MAPK was determined by protein immunoblot analysis by using anti-HA antibodies and was found to be similar in each sample. (B)
Effects of ARF6 on JNK activity. CHO cells were cotransfected with 5 mg of HA-tagged-JNK1 and 5 mg of the indicated constructs. Cells in lane 2 and 3 were treated
with EGF (50 ng/ml). JNK activity was measured by immunocomplex kinase assays using GST-Jun as substrate and was visualized by autoradiography. Expression of
JNK1 was determined by Western blot analysis by using anti-HA antibodies and was found to be similar in each sample.
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expressed and purified as a GST-fusion protein and was im-
mobilized on glutathione-Sepharose. Lysates of cells mock
transfected or transfected with ARF6(Q67L), with and without
LPA treatment, were passed over RBD-GST-Sepharose resin,
and bound Rho-GTP was assessed by SDS-PAGE followed by
immunoblot analysis with anti-RhoA antibody. As seen in Fig.
7, the dramatic increase in the levels of Rho-GTP that is
observed on treatment with LPA was not observed in the
presence of ARF6(Q67L). ARF6(Q67L) expression or LPA
treatment had no effect on the expression levels of Rho. These
observations suggest that activation of ARF6 antagonizes the
activation of RhoA induced by LPA. Thus, the activation of
ARF6 induces a down regulation of Rho function which results
in a depletion of stress fibers. In untreated cells, however,
expression of ARF6(Q67L) did not appear to have a significant
effect on Rho-GTP levels, although stress fiber formation was
inhibited. Thus, in addition to down regulating RhoA activa-
tion in response to extracellular stimulus, it is possible that
ARF6 may have an effect on actin-myosin complex assembly
required for stress fiber formation, independent of down reg-
ulation of Rho activation.
We then examined whether RhoA could induce actin stress
fibers in ARF6-expressing cells. Towards this end, mammalian
expression plasmids encoding an activated mutant of Rho,
Rho(G14V), and ARF6(Q67L) were cotransfected into CHO
cells, and actin filament distribution was visualized by staining
with rhodamine phalloidin. As shown in Fig. 8, in comparison
with cells expressing ARF6(Q67L) alone (panel B), abundant
stress fibers were observed in addition to peripheral rearrange-
ments in cells expressing both ARF6(Q67L) and Rho(G14V)
(panel C). Thus, the ARF6-induced inhibition of stress fiber
formation was overcome by coexpression of Rho(G14V). Ex-
pression of Rho(G14V) alone induced the formation of abun-
dant stress fibers without any effect on surface actin rearrange-
ments (data not shown). Coexpression of ARF6(T27N) had
no effect on the formation of stress fibers induced by RhoA
(data not shown). However, microinjection of the exoenzyme
C3 transferase, an inhibitor of endogenous Rho function, with
ARF6(Q67L) did not inhibit ARF6(Q67L)-induced actin re-
arrangements at the cell surface (Fig. 8). As shown in Fig. 8C
and D, microinjected cells (labeled with anti-ARF6) exhibited
prominent surface actin rearrangements and a depletion of
stress fibers. Microinjection of C3 transferase alone led to the
dissolution of stress fibers and had no significant effect on pe-
ripheral actin distribution (data not shown). Thus, inhibition of
endogenous Rho function had no effect on ARF6-induced ac-
tin remodeling.
DISCUSSION
In this study, we have documented an essential role for
ARF6 in membrane recycling and surface remodeling in re-
sponse to physiological stimulus and in the down regulation of
stress fiber formation. While ARF6 and Rac1 cooperate to
FIG. 6. Effect of LPA treatment on stress fiber formation in ARF6(Q67L)-expressing cells. ARF6-expressing serum-starved cells were treated with 1 mM LPA for
10 min at 37°C and were fixed and labeled with anti-ARF6 antibodies and phalloidin. ARF6(Q67L)-expressing cells were resistant to stress fiber formation, whereas
untransfected cells (arrow) exhibited stress fibers in response to LPA.
FIG. 7. Binding of Rho-GTP to RBD-GST. Lysates of cells transfected with
expression plasmids encoding indicated proteins were incubated with RBD-GST,
and bound Rho-GTP was analyzed by Western blotting with anti-RhoA poly-
clonal antibodies (upper panel). Cells lysates were resolved in SDS gels and were
immunoblotted for total Rho with anti-RhoA antibodies (lower panel).
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induce cortical actin rearrangements at the cell surface (in
response to bombesin), ARF6 down regulates RhoA activa-
tion, resulting in an inhibition of stress fiber formation. Our
findings are consistent with roles for ARF6, Rac1, and RhoA
in the coordinated regulation of actin filament organization.
The GTPases ARF6 and Rac1 regulate actin remodeling
and membrane traffic at the cell periphery (54). In this study,
we have shown that treatment of CHO cells with the extracel-
lular agonist bombesin, a bioactive peptide that has been im-
plicated in regulated secretion (50) and cell motility (1, 33),
resulted in increased cellular levels of ARF6-GTP which were
accompanied by the redistribution of ARF6 to the plasma
membrane and peripheral actin rearrangements. This process
was inhibited by ARF6(T27N), the dominant negative mutant
of ARF6. These data imply that bombesin is a bone fide phys-
iological trigger of ARF6 activation.
The molecular chain of events linking bombesin to ARF6
activation remains to be defined. However, one major player
involved appears to be the heterotrimeric G protein, Gq. We
found that the effect of bombesin on translocation of wild-type
ARF6 to the plasma membrane can be mimicked by the ex-
pression of activated Gaq. Furthermore, we demonstrated that
ARF6 redistribution to the cell surface was inhibited by ex-
pression of RGS2, a GAP for Gq that down regulates Gq
signaling. These observations have led us to conclude that Gq
is an upstream regulator of bombesin-induced ARF6 activa-
tion. How Gq activates ARF6 remains to be investigated. One
possible model is that bombesin induces the activation of Gaq,
which in turn activates ARF6 via an ARF6-specific guanine
nucleotide exchange factor (GEF) such as EFA6 (12), which
then induces the redistribution of the ARF6-positive endo-
somal compartment to the plasma membrane. More recently
it has been shown that activation of RhoA by LPA can be
mimicked by activated Ga12 and Ga13 in neuronal cell lines
(24). Furthermore, LPA has been shown to activate the Rho
exchange factor p115 via the activation of Ga13 (17, 22). Ac-
tivated Ga13 was demonstrated to interact with p115 and pro-
moted its ability to catalyze nucleotide exchange on Rho. It will
be of interest to determine whether a similar mechanism exists
for ARF6 activation.
In addition to its effect on cytoskeletal rearrangements,
bombesin has also been shown to trigger MAPK activation.
However, our results show that bombesin-induced MAPK ac-
tivation is independent of ARF6. Therefore, bombesin-medi-
ated activation of MAPK and cytoskeletal rearrangements oc-
cur via distinct pathways.
Since bombesin has previously been shown to trigger Rac
activation, resulting in the formation of membrane ruffles and
lamellipodia, we were interested in investigating whether the
bombesin-induced activation of ARF6 and Rac1 were linked.
We have shown that Rac1 partially overlaps with ARF6 on
perinuclear vesicles that are redistributed to the plasma mem-
brane on bombesin treatment. This recruitment of Rac1 to the
membrane was dependent on ARF6, since a dominant negative
mutant of ARF6 interfered with this event. These studies provide
a new model for bombesin-induced Rac1 activation, involving
ARF6-regulated endosomal recycling. At the plasma membrane,
activated ARF6 and Rac1 elicit distinct local changes that result
in cortical actin rearrangements. It is likely that a balance between
the activities of the ARF6 and Rac1 GTPases at the plasma
membrane will determine the overall morphology of the cell.
The model described above ascribes a role for membrane
traffic in the formation of actin rearrangements at the cell
periphery. We had previously shown that ARF6(T27N), the
dominant negative mutant of ARF6, does not block actin re-
arrangements induced by Rac1(G12V), the plasma-membrane
FIG. 8. Effect of Rho(G14V) and C3 transferase on ARF6(Q67L)-mediated cytoskeletal rearrangements. Untransfected cells (A), cells transfected with ARF6
(Q67L) (B), cells cotransfected with ARF6(Q67L) and Rho(G14V) (C), or cells microinjected with 0.3 mg of myrARF6(Q67L) per ml and 100 mg of C3 transferase
per ml (D and E) were fixed and labeled with rhodamine phalloidin to visualize actin filament distribution. Rho(G14V) induces stress fiber formation in ARF6
(Q67L)-expressing cells, and C3 transferase did not inhibit ARF6-mediated cytoskeletal rearrangements. Identification of microinjected cells was confirmed by labeling
with affinity-purified anti-ARF6 rabbit polyclonal antisera (E).
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associated, constitutively activated mutant of Rac1 (9). In ad-
dition, here we have shown that ARF6(T27N) did not interfere
with surface ruffling induced by the activated Rac1-GEF mu-
tant, C1199Tiam. These findings suggest that ARF6 does not
influence linear signaling components downstream of Rac1,
but aids in the recruitment of Rac1 to the cell surface in
response to specific extracellular stimuli. It should be noted,
however, that in some other cell types, such as HeLa cells,
ARF6(T27N) has been reported to inhibit actin rearrange-
ments induced by activated Rac1 (45). The discrepancy in
these observations is unclear and may likely be due to differ-
ences that exist in signaling pathways downstream of Rac ac-
tivation in different cell types.
Although our data clearly indicate a role for ARF6-medi-
ated endosomal recycling in Rac1-mediated actin remodeling,
several observations support the contention that other ARF6-
independent mechanisms may exist for Rac1 activation and its
subsequent biological activities. For instance, growth factors
such as PDGF that induce membrane ruffling via the activation
of Rac1 have no effect on the recruitment of vesicle-associated
Rac1 to the plasma membrane, and EGF-Rac1-stimulated JNK
activation occurs independently of ARF6. Furthermore, im-
munoelectron microscopy of cells expressing ARF6(T27N)
and wild-type Rac1 have shown that while all of the ARF6 mu-
tant is retained intracellularly, only a subpopulation of Rac1
(approximately 40%) is sequestered in the ARF6 endosome,
whereas 60% of the Rac1 label is present at the cell surface (P.
Peters and C. D’Souza-Schorey, unpublished observations). It
is likely that this plasma-membrane-associated Rac1 (as well as
cytosolic Rac1) may be activated by other mechanisms and by
other agonists that are independent of endosomal membrane
recycling and ARF6.
We have also investigated the relationship between ARF6
and Rho. These studies were prompted by our observation that
ARF6(Q67L), in addition to actin rearrangements at the cell
periphery, also induced a depletion of stress fibers (9). One
possible mechanism by which ARF6 exerts an effect on stress
fibers is by down regulating RhoA activation. Indeed, we have
found that cells expressing ARF6(Q67L) did not exhibit an
increase in Rho-GTP levels in response to treatment with
LPA, a lysophospholipid abundant in serum that has been
shown to induce the formation of stress fibers via the activation
of RhoA. Furthermore, stress fibers were readily formed in
cells expressing ARF6(Q67L) and the activated Rho mutant
Rho(G14V). The molecular mechanism by which ARF6 inhib-
its Rho activation remains unknown at this point. It is possible
that this regulation occurs at the level of Rho regulators, i.e.,
GEF, GAP, and guanine nucleotide dissociation inhibitor. In-
terestingly, P190, a Rho GAP, promotes the formation of ruf-
fles and neurite outgrowths in N1E-115 cells, whereas Tiam-
1-induced activation of Rac1 antagonizes Rho signaling during
neurite formation (55).
In the absence of LPA treatment, expression of ARF6
(Q67L) does not appear to have a significant effect on Rho-
GTP levels. Thus, in addition to down regulating RhoA acti-
vation in response to extracellular stimulus, it is possible that
ARF6 may have an effect on actin-myosin complex assembly
required for stress fiber formation. Recently, p21 adhesion
kinase, a downstream effector of Rac1 and Cdc42, has been
demonstrated to phosphorylate myosin light chain kinase (an
enzyme which phosphorylates myosin light chain), resulting in
decreased myosin light chain kinase activity and a loss of stress
fibers (51). Furthermore, van Leeuwen et al. have shown that
Rac1-regulated phosphorylation of the myosin heavy chain
(MHC) in PC12 cells leads to loss of cortical myosin II and cell
spreading in PC12 cells (56). Thus, MHC phosphorylation is a
yet another mechanism for actin-myosin complex disassembly.
It will be interesting to determine whether ARF6(Q67L) in-
duces a rearrangement of stress fibers by altering the phos-
phorylation status of MHC or myosin light chain. We are
investigating the role of ARF6 in stress fiber assembly in CHO
cells.
Membrane ruffles and protrusions are characteristically pres-
ent at the leading edge of motile cells, whereas stress fibers
that promote adhesion to the substratum correlate negatively
with cell locomotion. A strict balance between cell adhesion
and migration is fundamental to various cellular processes that
impinge on motility, such as invasion, axonal outgrowth, dia-
pedesis, chemotaxis, etc. Noteworthy is a recent study by No-
bes and Hall which showed that the dominant negative mutant
of Rac1 perturbed protrusive events in a wound healing assay,
whereas inactivation of Rho kinase, by the Rho kinase inhib-
itor Y-27632 (52), led to the dissolution of stress fibers and
enhanced cell movement during wound healing (40). Given the
effect of ARF6 on stress fiber formation and peripheral actin
rearrangements, it would be interesting to explore the possi-
bility that ARF6 may promote the wound healing process.
The findings presented in this study are supportive of pivotal
roles for ARF6 and the Rho family GTPases in the coordi-
nated regulation of cortical actin changes. The result is a com-
plex but well-controlled interplay of interdependent signaling
pathways in which small GTPases couple extracellular signals
from cell surface receptors to a spectrum of cellular responses.
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